Lodz, Poland

Konrad Rydzynski


Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Konrad Rydzynski: Innovator in Immunotoxicity Research

Introduction

Konrad Rydzynski is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of immunotoxicity through his innovative research and patented methods. His work focuses on the characterization of xenobiotic substances and their immunotoxic effects.

Latest Patents

Rydzynski holds a patent titled "Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances." This patent describes a method for characterizing tested substances, particularly useful in studying their toxicity, especially immunotoxicity. The patent also outlines cell lines and nucleic acids that can be utilized in this method, particularly for obtaining cell-chip collections intended for immunotoxicity assays.

Career Highlights

Throughout his career, Rydzynski has worked with several esteemed institutions. He has been associated with the National Institute of Public Health and the Environment, the Laboratory for Pathology and Immunobiology, and the Norwegian Institute of Public Health, specifically in the Division of Environmental Medicine. His work in these organizations has contributed to advancements in public health and environmental medicine.

Collaborations

Rydzynski has collaborated with notable colleagues, including Tove Ringerike and Robert Jan Vandehriel. These collaborations have further enriched his research and expanded the impact of his work in the field of immunotoxicity.

Conclusion

Konrad Rydzynski's contributions to immunotoxicity research through his patented methods and collaborations with esteemed institutions highlight his role as an innovator in this critical field. His work continues to influence the study of toxicity and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…